APAP 325 MG hydrocodone bitartrate 5 MG Oral Tablet

INDICATIONS AND USAGE Hydrocodone bitartrate and acetaminophen tablets, USP are indicated for the relief of moderate to moderately severe pain.

Rebel Distributors Corp

FDA Reported Adverse Reactions
`[1] off label use` `[2] fatigue` `[3] nausea` `[4] drug ineffective` `[5] diarrhoea` `[6] dyspnoea` `[7] pain` `[8] vomiting` `[9] toxicity to various agents` `[10] headache`

8 years ago

OVAL WHITE IP 109

8 years ago

IP 109 OVAL WHITE

HOW SUPPLIED Hydrocodone Bitartrate and Acetaminophen Tablets, USP, contain hydrocodone bitartrate 5 mg and acetaminophen 325 mg. They are supplied as white to off-white, scored, oblong biconvex tables, debossed "lP109" on obverse and bisected on the reverse. They are available as follows: Bottles of 15 NDC 21695-268-15 Bottles of 28 NDC 21695-268-28 Bottles of 30 NDC 21695-268-30 Bottles of 60 NDC 21695-268-60 Storage: Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°) [see USP Controlled Room Temperature]. A Schedule CIII Opioid.

More pills like OVAL IP 109

Related Pills

APAP 325 MG hydrocodone bitartrate 5 MG Oral Tablet

Rebel Distributors Corp

APAP 325 MG hydrocodone bitartrate 5 MG Oral Tablet

American Health Packaging

APAP 325 MG hydrocodone bitartrate 5 MG Oral Tablet

American Health Packaging

hydrocodone bitartrate and acetaminophen tablet

amneal pharmaceuticals of new york llc

APAP 325 MG hydrocodone bitartrate 5 MG Oral Tablet

American Health Packaging

APAP 325 MG hydrocodone bitartrate 5 MG Oral Tablet

American Health Packaging

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site